2015


Vaud


@sunbioscience Homepage

Company profile

SUN bioscience

Standardized cultures of stem cell-derived organoids, which are self-organizing 3D miniature tissues with organ-mimicking functions. The technology opens the door to personalized medicine, which means more effective treatments and fewer side effects than the current “one drug fits all” principle. SUN bioscience launched a clinical pilot to determine the efficacy of available medications on intestinal organoids grown from patients suffering from Cystic Fibrosis.


Source: startup.ch

More news about SUN bioscience

10.12.2018 09:57

Opening the door to personalized medicine

Launch
Please login or
register to use the
bookmark feature
21.02.2018 12:02

Top 16 of the W.A. De Vigier Awards are announced

Award
Please login or
register to use the
bookmark feature
06.12.2017 13:08

SUN Bioscience wins European start-up competition

Award
Please login or
register to use the
bookmark feature
14.12.2016 09:30

26 Startups selected for the IMD Startup Competition

Award
Please login or
register to use the
bookmark feature
19.05.2016 11:30

51 Swiss startups in the MassChallenge 2016 Cohort

Support
Please login or
register to use the
bookmark feature
06.04.2016 16:45

Venturelab presents the 20 Venture leaders of 2016

AwardSupport
Please login or
register to use the
bookmark feature
19.06.2015 14:00

SUN bioscience wins $100,000 at World Founder Forum

Award
Please login or
register to use the
bookmark feature
15.06.2015 20:40

And the winners of >>venture>> 2015 are: CUTISS and Pregnostics

Award
Please login or
register to use the
bookmark feature
04.06.2015 15:45

SUN Bioscience Selected for Investor FOUNDER.org’s Class of 2016

Award
Please login or
register to use the
bookmark feature
08.04.2015 09:22

Start-ups selected for EPFL Seed Night

Support
Please login or
register to use the
bookmark feature

By continuing to use this website you agree with our TERMS AND CONDITIONS